209 related articles for article (PubMed ID: 8556761)
1. [Growth and adult height in patients with congenital adrenal hyperplasia].
Kolousková S; Zemková D; Snajderová M; Lebl J
Cas Lek Cesk; 1995 Nov; 134(21):689-91. PubMed ID: 8556761
[TBL] [Abstract][Full Text] [Related]
2. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP; Winter A; Stolecke H
Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
[TBL] [Abstract][Full Text] [Related]
3. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W; Schwarz HP
Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
[TBL] [Abstract][Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
5. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
Rasat R; Espiner EA; Abbott GD
N Z Med J; 1995 Aug; 108(1005):311-4. PubMed ID: 7644165
[TBL] [Abstract][Full Text] [Related]
6. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
Bajpai A; Kabra M; Gupta AK; Menon PS
Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
[TBL] [Abstract][Full Text] [Related]
7. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM; Addo OY; Kyllo J; Gonzalez-Bolanos MT; Ltief AM; Pittock S; Himes JH; Miller BS; Sarafoglou K
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
[TBL] [Abstract][Full Text] [Related]
9. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
[TBL] [Abstract][Full Text] [Related]
10. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.
August GP; Julius JR; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):512-6. PubMed ID: 9685455
[TBL] [Abstract][Full Text] [Related]
11. Short-term growth in children with congenital adrenal hyperplasia.
Liivak K; Foster PJ; Thalange N; Tillmann V
Horm Res; 2009; 71(3):142-7. PubMed ID: 19188738
[TBL] [Abstract][Full Text] [Related]
12. Growth pattern and final height in 21-hydroxylase deficiency.
Bajpai A; Pandey RM; Kabra M; Menon PS
Indian Pediatr; 2007 Oct; 44(10):771-3. PubMed ID: 17998577
[TBL] [Abstract][Full Text] [Related]
13. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W; Schmidt H; Schwarz HP
Horm Res Paediatr; 2011; 75(1):32-7. PubMed ID: 20714115
[TBL] [Abstract][Full Text] [Related]
14. [The delay of bone maturation is a favorable element in the prognosis of final height].
Rochiccioli P; Tock Mine YY; Enjaume C; Dutau G; Sablayrolles B
Arch Fr Pediatr; 1985 Apr; 42(4):273-6. PubMed ID: 4004488
[TBL] [Abstract][Full Text] [Related]
15. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
Bretones P; Riche B; Pichot E; David M; Roy P; Tardy V; Kassai B; Gaillard S; Bernoux D; Morel Y; Chatelain P; Nicolino M; Cornu C;
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1379-1388. PubMed ID: 27852974
[TBL] [Abstract][Full Text] [Related]
16. Children born small for gestational age (SGA) who fail to achieve catch up growth by 2-8 years of age are short from infancy to adulthood. Data from a cross-sectional study of 486 Spanish children.
Carrascosa A; Vicens-Calvet E; Yeste D; Espadero RM; Ulied A;
Pediatr Endocrinol Rev; 2006 Sep; 4(1):15-27. PubMed ID: 17021579
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia.
Vilela MI; Viana MB
Pediatr Blood Cancer; 2007 Jan; 48(1):86-92. PubMed ID: 16700045
[TBL] [Abstract][Full Text] [Related]
19. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
Bajpai A; Sharma J; Kabra M; Gupta AK; Menon PS
Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
[TBL] [Abstract][Full Text] [Related]
20. Impact of growth hormone treatment on a Belgian population of short children with renal allografts.
Janssen F; Van Damme-Lombaerts R; Van Dyck M; Hall M; Schurmans T; Herman J; Hooghe L; Van Damme B
Pediatr Transplant; 1997 Nov; 1(2):190-6. PubMed ID: 10084780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
